UMediC Group Berhad Past Earnings Performance
Past criteria checks 2/6
UMediC Group Berhad has been growing earnings at an average annual rate of 22.5%, while the Healthcare industry saw earnings growing at 21.8% annually. Revenues have been growing at an average rate of 9.2% per year. UMediC Group Berhad's return on equity is 12.1%, and it has net margins of 16.8%.
Key information
22.5%
Earnings growth rate
16.1%
EPS growth rate
| Healthcare Industry Growth | 31.5% |
| Revenue growth rate | 9.2% |
| Return on equity | 12.1% |
| Net Margin | 16.8% |
| Last Earnings Update | 31 Oct 2024 |
Recent past performance updates
We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings
Jun 17
UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality
Dec 18Recent updates
UMediC Group Berhad's (KLSE:UMC) Returns On Capital Not Reflecting Well On The Business
Nov 11UMediC Group Berhad (KLSE:UMC) Hasn't Managed To Accelerate Its Returns
Aug 05We Think You Should Be Aware Of Some Concerning Factors In UMediC Group Berhad's (KLSE:UMC) Earnings
Jun 17UMediC Group Berhad's (KLSE:UMC) Earnings Are Of Questionable Quality
Dec 18Revenue Downgrade: Here's What Analysts Forecast For UMediC Group Berhad (KLSE:UMC)
Dec 12Some Investors May Be Worried About UMediC Group Berhad's (KLSE:UMC) Returns On Capital
Aug 11Robust Earnings May Not Tell The Whole Story For UMediC Group Berhad (KLSE:UMC)
Mar 13Is There An Opportunity With UMediC Group Berhad's (KLSE:UMC) 21% Undervaluation?
Nov 25Revenue & Expenses Breakdown
How UMediC Group Berhad makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Oct 24 | 53 | 9 | 12 | 0 |
| 31 Jul 24 | 55 | 9 | 11 | 0 |
| 30 Apr 24 | 52 | 9 | 10 | 0 |
| 31 Jan 24 | 50 | 10 | 9 | 0 |
| 31 Oct 23 | 49 | 10 | 8 | 0 |
| 31 Jul 23 | 45 | 10 | 8 | 0 |
| 30 Apr 23 | 41 | 8 | 8 | 0 |
| 31 Jan 23 | 38 | 7 | 8 | 0 |
| 31 Oct 22 | 44 | 6 | 9 | 0 |
| 31 Jul 22 | 51 | 6 | 10 | 0 |
| 31 Jul 21 | 34 | 5 | 6 | 0 |
| 31 Jul 20 | 24 | 2 | 5 | 0 |
| 31 Jul 19 | 16 | 1 | 4 | 0 |
Quality Earnings: UMC has high quality earnings.
Growing Profit Margin: UMC's current net profit margins (16.8%) are lower than last year (21%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: UMC's earnings have grown significantly by 22.5% per year over the past 5 years.
Accelerating Growth: UMC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: UMC had negative earnings growth (-12.3%) over the past year, making it difficult to compare to the Healthcare industry average (2.4%).
Return on Equity
High ROE: UMC's Return on Equity (12.1%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 09:21 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/07/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
UMediC Group Berhad is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ken-Wern Lim | Affin Hwang Investment Bank |
| Siu Li Chua | Hong Leong Investment Bank Berhad |
| Chee Siang | Hong Leong Investment Bank Berhad |